Zobrazeno 1 - 10
of 232
pro vyhledávání: '"non-muscle invasive bladder cancer (nmibc)"'
Autor:
Yuheng Wen, Zhihao Ming, Hong Li, Shuai Zhu, Jian Cao, Mingji Ye, Tian Gan, Xiangqun She, Yong Zeng, Yu Xie
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract This study aims to evaluate the prognostic utility of Activity-dependent neuroprotective protein (ADNP) expression in Circulating Tumor Cells (CTCs) inpatients with Non-muscle-invasive Bladder Cancer (NMIBC) undergoing Transurethral Resectio
Externí odkaz:
https://doaj.org/article/6b0757382eb1493b8df16958e5a5951a
Autor:
Karoline Brito Caetano Andrade Coelho, Denise Kusma Wosniaki, Anelis Maria Marin, Laura Fabris, Rodolfo Borges dos Reis, Mateus Nóbrega Aoki, Dalila Lucíola Zanette
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Bladder cancer (BC) is the second most common type of cancer of the urinary system. Approximately 75% of the cases are non-muscle invasive bladder cancer (NMIBC), which has a high recurrence and progression rate. Current diagnosis and surveillance me
Externí odkaz:
https://doaj.org/article/0725b12e970a4e148dfc4fcd4660c354
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThere is a sparsity of literature on treatment outcomes for patients with non-muscle invasive bladder cancer (NMIBC) who received neoadjuvant chemotherapy (NAC). We aim to analyze the outcomes associated with the use of NAC prior to radical
Externí odkaz:
https://doaj.org/article/8243223493704b729ee4467ca902cfc3
Autor:
Thura Kadhum, Silvia Selinski, Meinolf Blaszkewicz, Jörg Reinders, Emanuel Roth, Frank Volkert, Daniel Ovsiannikov, Oliver Moormann, Holger Gerullis, Dimitri Barski, Thomas Otto, Svetlana Höhne, Jan G. Hengstler, Klaus Golka
Publikováno v:
EXCLI Journal : Experimental and Clinical Sciences, Vol 22, Pp 867-879 (2023)
Urinary bladder cancer, a smoking and occupation related disease, was subject of several genome-wide association studies (GWAS). However, studies on the course of the disease based on GWAS findings differentiating between muscle invasive bladder canc
Externí odkaz:
https://doaj.org/article/84b2d27c9b95456eb35a270378795b24
Autor:
Beth Russell, Poppy Leech, Harriet Wylie, Charlotte Louise Moss, Anna Haire, Deborah Enting, Suzanne Amery, Kathryn Chatterton, Muhammad Shamim Khan, Ramesh Thurairaja, Rajesh Nair, Sachin Malde, Kate Smith, Cheryl Gillett, Debra Josephs, Elias Pintus, Sarah Rudman, Simon Hughes, Clare Relton, Mieke Van Hemelrijck
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
PurposeThe Graham Roberts Study was initiated in 2018 and is the first Trials Within Cohorts (TwiCs) study for bladder cancer. Its purpose is to provide an infrastructure for answering a breadth of research questions, including clinical, mechanistic,
Externí odkaz:
https://doaj.org/article/4b22b97093b047b19f688f0a5701018f
Autor:
Sarah Bazargan, Brittany Bunch, Awino Maureiq E. Ojwang‘, Jamie Blauvelt, Annick Landin, Johannes Ali, Dominique Abrahams, Cheryl Cox, Amy M. Hall, Matthew S. Beatty, Michael Poch, Katarzyna A. Rejniak, Shari Pilon-Thomas
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
BackgroundNew therapeutics in development for bladder cancer need to address the recalcitrant nature of the disease. Intravesical adoptive cell therapy (ACT) with tumor infiltrating lymphocytes (TIL) can potentially induce durable responses in bladde
Externí odkaz:
https://doaj.org/article/6a8fb4e5eb7f4745af9760012bdd39fc
Autor:
Ferry Safriadi, I Nyoman Palgunadi
Publikováno v:
Majalah Kedokteran Bandung, Vol 54, Iss 4, Pp 249-252 (2022)
Bladder cancer is the 10th most common cancer in both males and females with a ratio of 3:1. About 75% of bladder cancers are non-muscle invasive bladder cancers (NMIBC). The aim of this study was to identify the characteristics of Non-Muscle Invasiv
Externí odkaz:
https://doaj.org/article/1c5436a2fa5c417b80b458588ca74fa5
Autor:
Kristin Grabe-Heyne, Christof Henne, Paramananthan Mariappan, Götz Geiges, Johannes Pöhlmann, Richard F. Pollock
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Bladder cancer ranks among the most common cancers globally. At diagnosis, 75% of patients have non-muscle-invasive bladder cancer (NMIBC). Patients with low-risk NMIBC have a good prognosis, but recurrence and progression rates remain high in interm
Externí odkaz:
https://doaj.org/article/9ba46085efe34b2dbd6d09466ee11a05
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Frontiers in Surgery, Vol 10 (2023)
Bladder cancer is the most common malignant tumor of urinary system worldwide. Approximately 75% of patients with bladder cancer present with non-muscle-invasive bladder cancer (NMIBC), which is effectively managed with transurethral resection of bla
Externí odkaz:
https://doaj.org/article/f2b43f9b1dde4842ad7d5e3228397ac2